| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.094 | 0.05 |